(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.61%.
Anixa Biosciences's earnings in 2026 is -$11,115,000.On average, 6 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,583,462, with the lowest ANIX earnings forecast at -$12,258,259, and the highest ANIX earnings forecast at -$8,295,063. On average, 5 Wall Street analysts forecast ANIX's earnings for 2027 to be -$11,079,834, with the lowest ANIX earnings forecast at -$12,580,845, and the highest ANIX earnings forecast at -$8,295,063.
In 2028, ANIX is forecast to generate -$11,415,586 in earnings, with the lowest earnings forecast at -$10,967,916 and the highest earnings forecast at -$11,751,339.